
Microbial Sequencing Center (MSC)
Overview
The JCVI Microbial Sequence Center (MSC), sponsored by the National Institute for Allergies and Infectious Disease (NIAID), addresses the scientific community's need for additional sequencing of microorganisms and invertebrate vectors of disease that are considered agents of bioterrorism and/or responsible for emerging and re-emerging diseases. The MSC has the capacity to rapidly and cost-effectively sequence genomic DNA and provide preliminary identification of open reading frames and annotation of gene function for a wide variety of microorganisms, including viruses, bacteria, protozoa parasites, and fungi. A recommendation from a 2002 NIAID-sponsored Blue Ribbon Panel on Bioterrorism and its Implication for Biomedical Research was to support genomic sequencing of microorganisms considered agents of bioterrorism and related organisms. This recommendation included careful selection of species, strains, and clinical isolates to generate genomic data for different uses such as strain identification and targets for diagnostics, vaccines, antimicrobials, and other drug development.
Featured Highlights
Related Links
News Alert
On December 3rd, 2008, the NIAID Microbial Sequencing Centers announced annotation Release 1.0 of the Ixodes scapularis genome sequence (GenBank accession ABJB010000000.)
This annotation was produced jointly by the J. Craig Venter Institute, the VectorBase Bioinformatics Resource Center with support from the Broad Institute of Harvard/MIT. More information is available here.